Featured Research

from universities, journals, and other organizations

Microscope-based cell scanner will speed research into fat-busting drugs

Date:
May 6, 2010
Source:
American Friends of Tel Aviv University
Summary:
A new software-based tool fits onto a microscope like a pair of goggles, allowing a scientist to measure a broad number of physical parameters in the Petri dish while investigating fat cells. They might explore how fat cells change when given insulin, or how they react when treated with new experimental drug compounds.

Anglers rely on fish finders to help them locate the big catch. Now Tel Aviv University researchers in tissue engineering have developed a "fat finder" that can help scientists accelerate their research into new fat-melting drugs.

Related Articles


The new software-based tool, reported in a recent issue of the journal Tissue Engineering, fits onto a microscope like a pair of goggles and allows a scientist to measure a broad number of physical parameters in the Petri dish while investigating fat cells. They might explore how fat cells change when given insulin, or how they react when treated with new experimental drug compounds. Normally these kinds of questions need to be investigated with intensive pre-clinical and clinical trials -- an expensive and time-consuming process.

With the tool he invented, Prof. Amit Gefen of Tel Aviv University's Faculty of Engineering is able to address these questions at the cellular level -- by looking at individual fat cells to see what happens to them under experimental conditions. The tool allows scientists to see and assess quickly what is happening to each cell, and how individual cells change over time. Until now, fat tissues were studied as a whole, with little knowledge as to how cells react one by one. But a look at individual cells gives clues about the toxicity or effectiveness of a treatment almost immediately.

Cell squats and push-ups

Prof. Gefen's new research looks at lab-engineered fat cells. "Good for studying fat, the 'fat finder' is also a general purpose tool. It can save researchers time and money and help them answer questions in basic research and drug design," he says.

Prof. Gefen's tool gives scientists the ability to accurately measure what happens in live cell cultures over time. Equipped with algorithms to measure baseline cellular activity and compare it to how cells being experimented on behave, his device helps understand how fat tissue develops, so that "optimal" tissue-engineered fat can be produced as a biological substitute for treating wounds and in plastic surgery procedures.

Prof. Gefen is now adding other components to the microscope, such as a laser-based scan that can see cell slices in three dimensions. From these slices, he can make a computer model of the actual cell. Once the cell is "inside" the computer, it can be stretched and compressed mechanically via software controls under very specific parameters.

This tells Prof. Gefen how fat cells in different parts of the body react to pressure due to immobility, for example. "Our starting point is the chronic wounds field, but if you're a brain researcher, you can use it to see how neurons respond to pressure," he says.

Tissue made to order

Dr. Gefen's interrelated tools open up many possibilities for basic biological research and drug development. Researchers will be able to "see" details of cellular events that can't be described by other methods. And the tools can help investigators planning drug studies and clinical trials to implement well-controlled and efficient tissue engineering protocols and experiments.

Until now Prof. Gefen's engineered fat cell cultures and software tool have been tested using animal cells, but Prof. Gefen plans to do similar studies based on human fat cells. In addition to helping drug developers come up with more effective anti-obesity drugs, Prof. Gefen's research seeks to know more about paraplegics and how their weight gain affects other cells and body processes. With this information in hand, he hopes to be able to devise better injury prevention and treatment regimens.


Story Source:

The above story is based on materials provided by American Friends of Tel Aviv University. Note: Materials may be edited for content and length.


Cite This Page:

American Friends of Tel Aviv University. "Microscope-based cell scanner will speed research into fat-busting drugs." ScienceDaily. ScienceDaily, 6 May 2010. <www.sciencedaily.com/releases/2010/05/100506112640.htm>.
American Friends of Tel Aviv University. (2010, May 6). Microscope-based cell scanner will speed research into fat-busting drugs. ScienceDaily. Retrieved March 6, 2015 from www.sciencedaily.com/releases/2010/05/100506112640.htm
American Friends of Tel Aviv University. "Microscope-based cell scanner will speed research into fat-busting drugs." ScienceDaily. www.sciencedaily.com/releases/2010/05/100506112640.htm (accessed March 6, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, March 6, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Bupa Eyes India Healthcare Opportunities

Bupa Eyes India Healthcare Opportunities

Reuters - Business Video Online (Mar. 5, 2015) Bupa is hoping to expand in India&apos;s fast-growing health insurance market, once a rule change on foreign investment is implemented. The British private healthcare group&apos;s CEO tells Grace Pascoe why it&apos;s so keen on the new opportunity. Video provided by Reuters
Powered by NewsLook.com
Doctor in Your Pocket Is Getting Smarter

Doctor in Your Pocket Is Getting Smarter

Reuters - Business Video Online (Mar. 5, 2015) Mobile apps are turning smartphones into a personal doctors, with users able to measure heart rate, blood pressure and even blood sugar. But will it change our behaviour? Ivor Bennett reports from the Mobile World Congress in Barcelona. Video provided by Reuters
Powered by NewsLook.com
AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

Newsy (Mar. 5, 2015) AbbVie announced Wednesday it will buy cancer drugmaker Pharmacyclics in a $21 billion deal. Video provided by Newsy
Powered by NewsLook.com
Toddlers Drinking Coffee? Why You Shouldn't Share Your Joe

Toddlers Drinking Coffee? Why You Shouldn't Share Your Joe

Newsy (Mar. 5, 2015) A survey of Boston mothers and toddlers found that 15 percent of two-year-olds drink coffee and 2.5 percent of 1-year-olds. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins